Conexeu Sciences is trading 10.14% higher at $3.80 in pre-market on October 9, 2026, with no confirmed catalyst identified.
- The price compares with the October 8 close of $3.45; provided context also records an 8.35% after-hours gain to $3.74 that day.
- The latest press release, dated October 6, described progress toward a planned first-quarter 2027 FDA 510(k) submission, but does not establish a direct cause for the current move.